{ "labelLang" : "eng", "responseDate" : "2024-03-28 21:22", "content" : { "otype" : "BookChapter", "mtid" : 25239341, "status" : "ADMIN_APPROVED", "published" : true, "unhandledTickets" : 0, "oldTimestamp" : "2016-04-27T13:21:36.000+0000", "deleted" : false, "oldId" : 15239341, "lastRefresh" : "2023-08-19T16:48:29.483+0000", "lastModified" : "2016-04-27T13:21:36.000+0000", "created" : "2015-12-21T13:53:32.000+0000", "creator" : { "otype" : "Author", "mtid" : 10006399, "link" : "/api/author/10006399", "label" : "Judit Nagy (Nephrológia)", "familyName" : "Nagy", "givenName" : "Judit", "published" : true, "oldId" : 10006399, "snippet" : true }, "lastDuplumOK" : "2020-03-29T22:40:33.509+0000", "lastDuplumSearch" : "2020-03-29T22:40:33.509+0000", "adminApproved" : "2016-04-27T13:21:36.000+0000", "adminApprover" : { "otype" : "Admin", "mtid" : 10022754, "link" : "/api/admin/10022754", "label" : "Róbert Milánkovics (PTE ÁOK admin 5)", "familyName" : "Milánkovics", "givenName" : "Róbert", "published" : true, "oldId" : 10022754, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Chapter in Book", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000398, "link" : "/api/subtype/10000398", "label" : "Chapter (Chapter in Book)", "name" : "Könyvfejezet", "nameEng" : "Chapter", "docType" : { "otype" : "PublicationType", "mtid" : 25, "link" : "/api/publicationtype/25", "label" : "Chapter in Book", "code" : 25, "otypeName" : "BookChapter", "listPosition" : 2, "published" : true, "oldId" : 25, "snippet" : true }, "listPosition" : 220, "published" : true, "oldId" : 10000398, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Scientific", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "English", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Aamir, Ali M", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 43352485, "link" : "/api/authorship/43352485", "label" : "Aamir, Ali M", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Aamir", "givenName" : "Ali M", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Author", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 76065845, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 43352486, "link" : "/api/authorship/43352486", "label" : "Cohen, SD", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Cohen", "givenName" : "SD", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Author", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 76065844, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 43352487, "link" : "/api/authorship/43352487", "label" : "Kimmel, PL", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Kimmel", "givenName" : "PL", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Author", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 76065843, "snippet" : true } ], "title" : "Hepatitis B Virus", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 10067554, "link" : "/api/publicationidentifier/10067554", "label" : "DOI: 10.1002/9781444303391.ch24", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "NO", "idValue" : "10.1002/9781444303391.ch24", "realUrl" : "https://doi.org/10.1002/9781444303391.ch24", "published" : false, "oldId" : 10770757, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 10067553, "link" : "/api/publicationidentifier/10067553", "label" : "Scopus: 84891022364", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "NO", "idValue" : "84891022364", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-84891022364", "published" : false, "oldId" : 10770756, "snippet" : true } ], "firstPage" : "263", "lastPage" : "271", "firstPageOrInternalIdForSort" : "263", "pageLength" : 9, "publishedYear" : 2009, "digital" : null, "printed" : null, "sourceYear" : 2015, "packet" : "(Nagy Judit (Nephrológia); 2015.12.21. 14:52:27)", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-08-19", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 1, "citedCount" : 1, "referenceList" : "Lai C.L., Ratziu V., Yuen M.F., Poynard T., Viral hepatitis B (2003) Lancet, 362, pp. 2089-2094; \n\nLevy M., Chen N., Worldwide perspective of hepatitis B-associated glomerulonephritis in the 80s (1991) Kidney Int, 40 (SUPPL. 35), pp. S24; \n\nNair S., Perillo R.P., Hepatitis B and D (2003) Hepatology:a Textbook of Liver Disease, pp. 959-961. , In:Zakim D, Boyer TD, editors., 4th edn. WB Saunders, Philadelphia; \n\nLee W.M., Hepatitis B virus infection (1997) N Engl J Med, 337, pp. 1733-1745; \n\nTiollais P., Pourcel C., Dejean A., The hepatitis B virus (1985) Nature, 317, p. 489; \n\nKimmel P.L., Moore Jr. J., Viral glomerular diseases (2006) Diseases of the Kidney and Urinary Tract:Clinicopathologic Foundations of Medicine, pp. 1478-1510. , In:Schrier R, editor., 8th edn. Lippincott, Williams & Wilkins, Baltimore; \n\nLi J., Buckwold V.E., Hon M.W., Ou J.H., Mechanisms of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation (1999) J Virol, 73, pp. 1239-1244; \n\nMahoney F.J., Update on diagnosis, management, and prevention of hepatitis B virus infection (1999) Clin Microbiol Rev, 12, pp. 351-366; \n\nHyams K.C., Risks of chronicity following acute hepatitis B virus infections:a review (1995) Clin Infect Dis, 20, pp. 992-1000; \n\nCombes B., Shorey J., Barrera A., Stastny P., Eigenbrodt E.H., Hull A.R., Glomerulonephritis with deposition of Australia antigen-antibody complexes in the glomerular basement membrane (1971) Lancet, II, pp. 234-237; \n\nBhimma R., Coovadia H.M., Hepatitis B virus-associated nephropathy (2004) Am J Nephrol, 24, pp. 198-211; \n\nGilbert R.D., Wiggelinkhuizen J., The clinical course of hepatitis B-associated nephropathy (1994) Pediatr Nephrol, 8, pp. 11-14; \n\nChing-Yuang L., Clinical features and natural course of HBV-related glomerulopathy in children (1991) Kidney Int, 40 (SUPPL. 35), pp. 46-53; \n\nJohnson R.J., Couser W.G., Hepatitis B infection and renal disease:clinical, immunopathogenetic and therapeutic considerations (1990) Kidney Int, 37, pp. 663-676; \n\nKneiser M.R., Jenis E.H., Lowenthal D.T., Bancroft W.H., Burns W., Shalhoub R., Pathogenesis of renal disease associated with viral hepatitis (1974) Arch Pathol, 97, p. 193; \n\nRonco P., Verroust P., Morel-Maroger L., Viruses and glomerulonephritis (1982) Nephron, 31, p. 97; \n\nLai K.N., Lai F.M., Chan K.W., Chow C.B., Tong K.L., Vallance-Owen J., The clinico-pathologic features of hepatitis B-associated glomerulonephritis (1987) QJM, 63, pp. 323-333; \n\nCoovadia H.M., Adhikari M., Morel-Maroger L., Clinico-pathological features of the nephrotic syndrome in South Africa (1979) QJM, 48, pp. 77-91; \n\nSlusarczyk J., Michalak T., Nazarewicz-De Mezer T., Krawczynski K., Nowoslawski A., Membranous glomerulonephritis associated hepatitis B core antigen immune complexes (1980) Am J Pathol, 98, pp. 29-39; \n\nKohler P.F., Cronin R.E., Hammond W.S., Olin D., Carr R.I., Chronic membranous glomerulonephritis caused byhepatitis B antigen-antibodyim-mune complexes (1974) Ann Intern Med, 81, pp. 448-451; \n\nLee H.S., Choi Y., Yu S.H., Koh H.I., Kim M.J., Ko K.W., A renal biopsy study of hepatitis B virus-associated nephropathy in Korea (1988) Kidney Int, 34, pp. 537-543; \n\nMaggiore Q., Bartolomeo F., L'Abbate A., Misefari V., HBsAg glomerular deposits in glomerulonephritis:fact or artifact? (1981) Kidney Int, 19, pp. 579-586; \n\nHiroshi H., Udo K., Kojima M., Takahashi Y., Miyakawa Y., Miyamoto K., Deposition of HB e antigen in membranous glomerulonephritis:identification by F(ab/)2 fragments of monoclonal antibody (1984) Kidney Int, 26, p. 338; \n\nHe X.Y., Fang L.J., Zhang Y.E., Sheng F.Y., Zhang X.R., Guo M.Y., In situ hybridization of hepatitis B DNA in hepatitis B-associated glomerulonephritis (1998) Pediatr Nephrol, 12, pp. 117-120; \n\nLai K.N., Ho R.T., Tam J.S., Lai F.M., Detection of hepatitis B virus DNA and RNA in kidneys of HBV-related glomerulonephritis (1996) Kidney Int, 50, pp. 1965-1977; \n\nZhou S.D., The study of the significance of the appearance of HBcAg in glomerulonephritis (1995) Chin J Nephrol, 11, pp. 104-106; \n\nVenkataseshan V.S., Lieberman K., Kim D.U., Thung S.N., Dikman S., D'Agati V., Hepatitis-B-associated glomerulonephritis:pathology, pathogenesis, and clinical course (1990) Medicine, 69, p. 200; \n\nNagy J., Bajtai G., Brasch H., Sule T., Ambrus M., Deak G., The role of hepatitis B surface antigen in the pathogenesis of glomerulopathies (1979) Clin Nephrol, 12, p. 109; \n\nMizushima N., Kanai K., Matsuda H., Matsumoto M., Tamakoshi K., Ishii H., Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon (1987) Gastroenterology, 92, pp. 524-526; \n\nEsteban R., Buti M., Valles M., Allende H., Guardia J., Hepatitis B-associated membranous glomerulonephritis treated with adenine arabinoside monophosphate (1986) Hepatology, 6, pp. 762-763; \n\nTakekoshi Y., Tanaka M., Miyakawa Y., Yoshizawa H., Takahashi K., Mayumi M., Free \"small\" and IgG associated \"large\" hepatitis B e antigen in the serum and glomerular capillarywalls of two patients with membranous glomerulonephritis (1979) N Engl J Med, 300, pp. 814-819; \n\nDe Man R.A., Schalm S.W., Van Der Heijden A.J., Ten Kate F.W., Wolff E.D., Hetjtink R.A., Improvement of hepatitis B associated glomerulonephritis after antiviral combination therapy (1989) J Hepatol, 8, pp. 367-372; \n\nSchectman J.M., Kimmel P.L., Remission of hepatitis B-associated membranous glomerulonephritis in human immunodeficiency virus infection (1991) Am J Kidney Dis, 17, pp. 716-718; \n\nLai K.N., Li P.K., Au T.C., Tam J.S., Tong K.L., Lai F.M., Membranous nephropathy related to hepatitis B virus in adults (1991) N Engl J Med, 324, pp. 1457-1463; \n\nLai F.M., Lai K.N., Tam J.S., Lui S.F., To K.F., Li P.K., Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens (1994) Am J Surg Pathol, 18, pp. 175-186; \n\nAbbas N.A., Pitt M.A., Green A.T., Solomon L.R., Successful treatment of HBV-associated MPGN with alpha interferon (1999) Nephrol Dial Transplant, 14, pp. 1272-1275; \n\nSchmitt H., Bohle A., Reineke T., Mayer-Eichberger D., Vogl W., Longterm prognosis of membranoproliferative glomerulonephritis type-I (1990) Nephron, 55, pp. 242-250; \n\nMeyers C.M., Seeff L.B., Stehman-Breen C.O., Hoofnagle J.H., Hepatitis C and renal disease:an update (2003) Am J Kidney Dis, 42, pp. 631-637; \n\nPonticelli C., Zucchelli P., Passerini P., Cagnoli L., Cesana B., Pozzi C., A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy (1989) N Engl J Med, 320, pp. 8-13; \n\nTang S., Chan T.M., Cheng I.K., Lai K.N., Clinical features and treatment outcome of idiopathic membranous nephropathy in Chinese patients (1999) QJM, 92, pp. 401-406; \n\nCattran D., Management of membranous nephropathy:when and what for treatment (2005) J Am Soc Nephrol, 16, pp. 1188-1194; \n\nPonticelli C., Altieri P., Scolari F., Passerini P., Roccatello D., Cesana B., A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy (1998) J Am Soc Nephrol, 9, pp. 444M50; \n\nLai K.N., Tam J.S., Lin H.J., Lai F.M., The therapeutic dilemma of usage of corticosteroids in patients with membranous nephropathy and persistent hepatitis B surface antigenemia (1990) Nephron, 54, pp. 12-17; \n\nLin C.Y., Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha interferon (1991) Kidney Int, 47, pp. 225-230; \n\nBhimma R., Coovadia H.M., Kramvis A., Adhikari M., Kew M.C., Treatment of hepatitis B virus-associated nephropathy in black children (2002) Pediatr Nephrol, 17, pp. 393-399; \n\nStein D.F., Ahmed A., Sunkhara V., Khalbuss W., Collapsing focal segmental glomerulosclerosis with recovery of renal function:an uncommon complication of interferon therapy for hepatitis C (2001) Dig Dis Sci, 46, pp. 530-535; \n\nDressler D., Wright J.R., Houghton J.B., Kalra P.A., Another case of focal segmental glomerulosclerosis in an acutely uremic patient following interferon therapy (1999) Nephrol Dial Transplant, 14, pp. 2049-2050; \n\nHaas M., Jager U., Mayer G., Interferon alpha-2c and proteinuria in a patient with focal and segmental glomerulosclerosis (1997) Lancet, 349, pp. 1147-1148; \n\nCoreneos E., Petrusevska G., Varghese F., Truong L.D., Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy (1996) Am J Kidney Dis, 28, pp. 888-892; \n\nAuty A., Nephrotic syndrome in a multiple sclerosis patient treated with interferon beta 1a (2005) Can J Neurological Sci, 32, pp. 366-368; \n\nZuber J., Alpha-interferon associated thrombotic microangiopathy (2002) Medicine, 81, pp. 321-331; \n\nHerrman J., Membranoproliferative glomerulonephritis in a patient with hairy-cell leukemia treated with alpha-II interferon (1987) N Engl J Med, 316, pp. 112-113; \n\nMiranda-Guardiola F., Acute renal failure associated with alpha-interferon therapy for chronic hepatitis B (1995) Nephrol Dial Transplant, 10, pp. 1441-1443; \n\nKimmel P.L., Abraham A.A., Phillips T.M., Membranoproliferative glomerulonephritis in a patient treated with interferon-alpha for HIV infection (1994) Am J Kidney Dis, 24, pp. 858-863; \n\nJones G.J., Itri L.M., Safetyand tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients (1986) Cancer, 57, pp. 1709-1715; \n\nQuesada J.R., Talpaz M., Rios A., Kurzrock R., Gutterman J.U., Clinical toxicity of interferons in cancer patients:a review (1986) J Clin Oncol, 4, pp. 234-243; \n\nAyub A., Acute renal failure with alpha interferon therapy:a case report (1993) Med Sci Res, 21, pp. 123-124; \n\nWilson R.A., Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C (2002) J Clin Gastroenterol, 35, pp. 89-92; \n\nDimitrov Y., Heibel F., Marcellin L., Chantrel F., Moulin B., Hannedouche T., Acute renal failure and nephrotic syndrome with alpha interferon therapy (1997) Nephrol Dial Transplant, 12, pp. 200-203; \n\nOhta S., Yokoyama H., Wada T., Sakai N., Shimizu M., Kato T., Exacerbation of glomerulonephritis in subjects with chronic hepatitis C infectionafter interferon therapy (1999) Am J Kidney Dis, 33, pp. 1040-1048; \n\nCooksley W.G., Treatment of hepatitis B with interferon and combination therapy (2004) Clin Liver Dis, 8, pp. 353-370; \n\nCooksley W.G., Treatment with interferons (including pegylated interferons) in patients with hepatitis B (2004) Semin Liver Dis, 1, p. 4553; \n\nMarcellin P., Lau G.K., Bonino F., Farci P., Hadziyannis S., Jin R., Pegin-terferon alfa-2a alone, lamivudine alone, and the two in combination in patients with Hbe Ag negative chronic hepatitis B (2004) N Engl J Med, 351, pp. 1206-1217; \n\nLau G.K., Piratvisuth T., Luo K.X., Marcellin P., Thonsawat S., Cooksley G., Peginterferon alfa, lamivudine, and the combination for Hbe Ag positive chronic hepatitis B (2005) N Engl J Med, 352, pp. 2682-2695; \n\nJanssen H.L., Van Zonneveld M., Senturk H., Zeuzem S., Akarca U.S., Cakaloglu Y., Pegylated interferon alfa-2b alone or in combination with lamivudine for HBe Ag positive chronic hepatitis B:a randomised trial (2005) Lancet, 365, pp. 123-129; \n\nTang S., Lai F.M., Lui Y.H., Tank C.S., Kung N.N., Ho Y.W., Lamivudine in hepatitis B-associated membranous nephropathy (2005) Kidney Int, 68, pp. 1750-1758; \n\nGan S.I., Devlin S.M., Scott-Douglas N.W., Burak K.W., Lamivudine for the treatment of membranous glomerulopathy secondary to chronic hepatitis B infection (2005) Can J Gastroenterol, 19, pp. 625-629; \n\nOkuse C., Yotsuyanagi H., Yamada N., Ikeda H., Takahashi H., Suzuki M., Successful treatment of hepatitis B virus-associated membranous nephropathy with lamivudine (2006) Clin Nephrol, 65, pp. 53-56; \n\nFiller G., Another case of HBV associated membranous glomerulonephritis resolving on lamivudine (2003) Arch Dis Child, 88, p. 460; \n\nConnor F.L., Rosenberg A.R., Kennedy S.E., Bohane T.D., HBV-associated nephrotic syndrome:resolution with oral lamivudine (2003) Arch Dis Child, 88, pp. 446-449; \n\nLok A.S., Lai C.L., Leung N., Yao G.B., Cui Z.Y., Schiff E.R., Long term safety of lamivudine treatment in patients with chronic hepatitis B (2003) Gastroenterology, 125, pp. 1714-1722; \n\nMarcellin P., Chang T.T., Lim S.G., Tong M.J., Sievert W., Shiffman M.L., Adefovir dipivoxil for the treatment of HBe Ag positive chronic hepatitis B (2003) N Engl J Med, 348, pp. 808-816; \n\nHadziyannis S.J., Adefovir dipivoxil for the treatment of HBe Ag negative hepatitis B (2003) N Engl J Med, 348, pp. 800-807; \n\nIzzedine H., Hulot J.S., Launay-Vacher V., Marcellini P., Hadziyannis S.J., Currie G., Renal safety of adefovir dipivoxil in patients with chronic hepatitis B:two double-blind randomized, placebo-controlled studies (2004) Kidney Int, 66, pp. 1153-1158; \n\nFontaine H., Vallet-Pichard A., Chaix M.L., Currie G., Serpaggi J., Verkarre V., Efficacy and safety of adefovir dipivoxil in kidney recipients, hemodialysis patients, and patients with renal insufficiency (2005) Transplantation, 80, pp. 1086-1092; \n\nChang T.T., Gish R.G., De Man R., Gadano A., Sollano J., Chao Y.C., A comparison of entecavir and lamivudine for HBe Ag positive chronic hepatitis B (2006) N Engl J Med, 354, pp. 1001-1010; \n\nLai C.L., Shouval D., Lok A.S., Chang T.T., Cheinquer H., Goodman Z., Entecavir versus lamivudine for patients with HBe Ag negative chronic hepatitis B (2006) N Engl J Med, 354, pp. 1011-1020; \n\nIzzedine H., Isnard-Bagnis C., Hulot J.S., Vittecoq D., Cheng A., Jais C.K., Renal safety of tenofovir in HIV treatment experienced patients (2004) AIDS, 18, pp. 1074-1075; \n\nIzzedine H., Launay-Vacher V., Deray G., Antiviral drug-induced nephrotoxicity (2005) Am J Kidney Dis, 45, pp. 804-817; \n\nAnneli M.G., Torres D.D., Manno C., Scioscia C., Iannone F., Covelli M., Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab (2005) Arthritis Rheum, 52, pp. 2519-2520; \n\nHan S.B., Extrahepatic manifestations of chronic hepatitis B (2004) Clin Liver Dis, 8, pp. 403-418; \n\nDienstag J.L., Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection (1981) Springer Semin Immunopathol, 3, pp. 461-472; \n\nSchusterman N., London W.T., Hepatitis B and immune complex disease (1984) N Engl J Med, 310, pp. 43-46; \n\nFrye K.H., Becker M.J., Theofilopoulos A.N., Moutsopoulos H., Feldman J.L., Talal N., Immune complexes in hepatitis B antigen-associated periarteritis nodosa:detection by antibody dependent cell-mediated cytotoxicity and the Raji cell assay (1977) Am J Med, 62, pp. 783-791; \n\nGocke D.J., Jsu K., Morgan C., Bombardierei S., Lockshin M., Christian C.L., Association between polyarteritis and Australia antigen (1970) Lancet, II, pp. 1149-1153; \n\nMichalak T., Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa:a study of seven necropsy cases (1978) Am J Pathol, 90, pp. 619-632; \n\nTrepo C., Guillevin L., Polyarteritis nodosa and extrahepatic manifestations of HBV infection:the case against autoimmune intervention in pathogenesis (2001) J Autoimmun, 16, pp. 269-274; \n\nColmegna I., Maldonado-Coco J.A., Polyarteritis nodosa revisited (2005) Curr Rheumatol Rep, 7, pp. 288-296; \n\nDeleaval P., Stadler P., Descombes E., Hecker E., Schrago G., Chizzolini C., Life threatening complications of HBV-related polyarteritis nodosa developing despite interferon alpha-2b therapy:successful treatment with a combination of interferon, lamivudine, plasma exchange and steroids (2001) Clin Rheumatol, 20, pp. 290-292; \n\nGuillevin L., Lhote F., Sauvaget F., Deblois P., Rossi F., Levallois D., Treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha and plasma exchanges (1994) Ann Rheum Dis, 53, pp. 334-337; \n\nGuillevin L., Lhote F., Cohen P., Sauvaget F., Jarrousse B., Lortholary O., Polyarteritis nodosarelated to hepatitis B virus:a prospective studywith long term observation of 41 patients (1995) Medicine, 74, p. 238; \n\nGuillevin L., Mahr A., Callard P., Godmer P., Pagnoux C., Leray E., Hepatitis B virus associated polyarteritis nodosa:clinical characteristics, outcome, and clinical impact of treatment in 115 patients (2005) Medicine, 84, pp. 313-322; \n\nLevo Y., Gorevic P.D., Kassab H.J., Zucker-Franklin D., Franklin E.C., Association between hepatitis B virus and essential mixed cryoglobulinemia (1977) N Engl J Med, 296, pp. 1501-1504; \n\nFerri C., Mixed cryoglobulinemia:demographic, clinical, and serologic features and survival in 231 patients (2004) Semin Arthritis Rheum, 33, pp. 355-374; \n\nWang N.S., Wu Z.L., Zhang Y.E., Liao L.T., Existence and significance of hep-atitis B virus DNA in kidneys of IgA nephropathy (2005) World J Gastroenterol, 11, pp. 712-716; \n\nIda H., Izumino K., Asaka M., Fujita M., Takata M., Sasayama S., IgA nephropathy and hepatitis B virus. IgA nephropathy unrelated to hepatitis B surface antigenemia (1990) Nephron, 54, pp. 18-20; \n\nLai K.N., Lai F.M., Lo S., Ho C.P., Chan K.W., IgA nephropathy associated with hepatitis B virus antigenemia (1987) Nephron, 47, pp. 141-143; \n\nLai K.N., Lai F.M., Clinical features and the natural course of hepatitis B virus related glomerulopathy in adults (1991) Kidney Int, 40, pp. S40-S45; \n\nTakeda S., Kida H., Katagiri M., Yokoyama H., Abe T., Hattori N., Characteristics of glomerular lesions in hepatitis B virus infection (1988) Am J Kidney Dis, 11, pp. 57-62; \n\nFabrizi F., Bunnapradist S., Martin P., HBV infection in patients with end-stage renal disease (2004) Semin Liver Dis, 24, pp. 63-70; \n\nBurdick R.A., Bragg-Gresham J.L., Woods J.D., Hedderwick S.A., Kurokawa K., Combe C., Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents. The DOPPS (2003) Kidney Int, 63, pp. 2222-2229; \n\nRodrigues A., Morgado T., Areias J., Silvestre F., Pinho L., Alves H., Limited benefits of IFN-alpha therapy in renal graft candidates with chronic viral hepatitis B or C (1997) Transplant Proc, 29, pp. 777-780; \n\nChan T.M., Fang G.X., Tang C.S., Cheng I., Lai K.N., Ho S.K., Preemptive lamivudine therapybased on HBV DNA level in HBsAg-positive kidney allograft recipients (2002) Hepatology, 36, pp. 1246-1252; \n\nFornairon S., Pol S., Legendre C., Carnot F., Mamzer-Bruneel M.F., Brechot C., The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B infection (1996) Transplantation, 62, pp. 297-299; \n\nAroldi A., Lampertico P., Montagnino G., Passerini P., Villa M., Campise M.R., Natural historyofhepatitis B and C in renal allograft recipients (2005) Transplantation, 79, pp. 1132-1136; \n\nSchwarz A., Krause P.H., Offermann G., Keller F., Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation (1994) Transplantation, 58, pp. 650-654", "hasCitationDuplums" : false, "userChangeableUntil" : "2016-04-27T13:21:36.000+0000", "publishDate" : "2015-12-21T14:08:19.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 1, "ownerInstituteCount" : 5, "directInstituteCount" : 0, "authorCount" : 3, "contributorCount" : 0, "book" : { "otype" : "Book", "mtid" : 30130877, "link" : "/api/publication/30130877", "label" : "Donald A. Molony. Evidence-Based Nephrology. (2009) ISBN:9781405139755", "core" : false, "citation" : false, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Book", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000201, "link" : "/api/subtype/10000201", "label" : "Monograph (Book)", "name" : "Szakkönyv", "nameEng" : "Monograph", "docType" : { "otype" : "PublicationType", "mtid" : 23, "link" : "/api/publicationtype/23", "label" : "Book", "code" : 23, "otypeName" : "Book", "listPosition" : 3, "published" : true, "oldId" : 23, "snippet" : true }, "listPosition" : 337, "published" : true, "oldId" : 10000201, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Scientific", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "English", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "title" : "Evidence-Based Nephrology", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 7070975, "link" : "/api/publicationidentifier/7070975", "label" : "ISBN: 9781405139755", "source" : { "otype" : "PlainSource", "mtid" : 122, "link" : "/api/publicationsource/122", "label" : "ISBN", "type" : { "otype" : "PublicationSourceType", "mtid" : 10002, "link" : "/api/publicationsourcetype/10002", "label" : "Egyéb", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "ISBN", "nameEng" : "ISBN", "linkPattern" : "https://www.worldcat.org/search?q=isbn%3A@@@", "publiclyVisible" : true, "published" : true, "oldId" : 122, "snippet" : true }, "idValue" : "9781405139755", "realUrl" : "https://www.worldcat.org/search?q=isbn%3A9781405139755", "published" : false, "snippet" : true } ], "publishedAt" : [ { "otype" : "City", "mtid" : 11237, "link" : "/api/city/11237", "label" : "[s.l.], International", "partOf" : { "otype" : "Country", "mtid" : 10165, "link" : "/api/country/10165", "label" : "International", "published" : true, "oldId" : 2151749, "snippet" : true }, "published" : true, "oldId" : 10000319, "snippet" : true } ], "pageLength" : 864, "publishedYear" : 2009, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : true, "published" : true, "snippet" : true }, "hasQualityFactor" : false, "link" : "/api/publication/25239341", "label" : "Aamir Ali M et al. Hepatitis B Virus. (2009) In: Evidence-Based Nephrology pp. 263-271", "template" : "